Metformin

Metformin

SCHEMBL10325534

CN(C)C(N)=NC(=N)N

nearest known ligand 0.00

Full drug profile on Sugi Atlas →

Known targets — ChEMBL curated mechanism

COXFA4COXFA4L2GPD2MT-ND1MT-ND2MT-ND3MT-ND4MT-ND4LMT-ND5MT-ND6NDUFA1NDUFA10NDUFA11NDUFA12NDUFA13NDUFA2NDUFA3NDUFA5NDUFA6NDUFA7NDUFA8NDUFA9NDUFAB1NDUFAF1NDUFAF2NDUFAF3NDUFAF4NDUFB1NDUFB10NDUFB11NDUFB2NDUFB3NDUFB4NDUFB5NDUFB6NDUFB7NDUFB8NDUFB9NDUFC1NDUFC2NDUFS1NDUFS2NDUFS3NDUFS4NDUFS5NDUFS6NDUFS7NDUFS8NDUFV1NDUFV2NDUFV3

The experimentally established mechanism targets of Metformin. The predicted profile below is derived independently by chemical similarity — agreement is a validation signal, a miss is honest.

⚠ Novel chemotype — no close known analogue (best Tanimoto < 0.3). Unexplored chemical space relative to ChEMBL.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
Metformin SCHEMBL9913821 1.00
Metformin SCHEMBL20140191 0.97 HTT (0.50)
Metformin SCHEMBL20140193 0.97 HTT (0.50)
Metformin SCHEMBL20139463 0.90 LMNA (0.41)
Metformin SCHEMBL28313216 0.90 LMNA (0.41)
Metformin SCHEMBL20141434 0.88 LMNA (0.39)
SCHEMBL19038528 0.82 LMNA (0.70)
SCHEMBL20865419 0.82 LMNA (0.70)
SCHEMBL20315915 0.80
SCHEMBL19038523 0.77 LMNA (0.48)

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 6 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
CN-110167542-A Nitrite salts of 1, 1-metformin, pharmaceutical compositions and methods of use 诺沃梅迪科斯有限公司 2019-08-23 CN disclosed
CN-105308121-A Resin composition AJINOMOTO KK 2016-02-03 CN disclosed
CN-104910823-A Adhesive film AJINOMOTO KK 2015-09-16 CN disclosed
CN-104045976-A Resin composition AJINOMOTO KK 2014-09-17 CN disclosed
EP-2663186-A1 LIPID-LOWERING ANTIDIABETIC AGENT Thetis Pharmaceuticals LLC (US) 2013-11-20 EP disclosed
WO-2012097144-A1 LIPID-LOWERING ANTIDIABETIC AGENT THETIS PHARMACEUTICALS LLC (US) 2012-07-19 WO disclosed